SYNDAX Trademark

Trademark Overview

On Wednesday, September 8, 2010, a trademark application was filed for SYNDAX with the United States Patent and Trademark Office. The USPTO has given the SYNDAX trademark a serial number of 85124983. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, March 16, 2023. This trademark is owned by Syndax Pharmaceuticals, Inc.. The SYNDAX trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Providing information in the field of cancer treatment; Providing links to the web sites of others featuring information about the diagnosis and treatment of cancer

Research and development of pharmaceuticals for the treatment of cancer; medical and scientific research services in the field of cancer treatment
syndax

General Information

Serial Number85124983
Word MarkSYNDAX
Filing DateWednesday, September 8, 2010
Status800 - REGISTERED AND RENEWED
Status DateThursday, March 16, 2023
Registration Number4294113
Registration DateTuesday, February 26, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 11, 2012

Trademark Statements

Goods and ServicesProviding information in the field of cancer treatment; Providing links to the web sites of others featuring information about the diagnosis and treatment of cancer
Goods and ServicesResearch and development of pharmaceuticals for the treatment of cancer; medical and scientific research services in the field of cancer treatment

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, September 12, 2010
Primary Code042
First Use Anywhere DateMonday, April 30, 2007
First Use In Commerce DateMonday, April 30, 2007
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, September 12, 2010
Primary Code044
First Use Anywhere DateMonday, April 30, 2007
First Use In Commerce DateMonday, April 30, 2007

Trademark Owner History

Party NameSyndax Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451
Party NameSyndax Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451
Party NameSyndax Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451

Trademark Events

Event DateEvent Description
Thursday, March 16, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, March 16, 2023REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, March 16, 2023REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, March 16, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, August 31, 2022TEAS SECTION 8 & 9 RECEIVED
Saturday, February 26, 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, June 1, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, June 1, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 1, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, June 1, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 1, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 1, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, March 28, 2019NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, March 28, 2019REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, March 28, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, February 21, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 21, 2019TEAS SECTION 8 & 15 RECEIVED
Monday, February 26, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, March 15, 2017APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 15, 2017TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, May 31, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, May 31, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, January 16, 2015APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, January 16, 2015TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, January 16, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, January 16, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 26, 2013REGISTERED-PRINCIPAL REGISTER
Tuesday, December 11, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 11, 2012PUBLISHED FOR OPPOSITION
Wednesday, November 21, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, November 8, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, November 2, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 10, 2012TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 10, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 10, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 10, 2012TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, July 3, 2012REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, December 29, 2011REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, December 27, 2011ASSIGNED TO LIE
Tuesday, December 27, 2011ASSIGNED TO LIE
Friday, June 24, 2011REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, June 24, 2011ASSIGNED TO LIE
Saturday, December 18, 2010NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Saturday, December 18, 2010LETTER OF SUSPENSION E-MAILED
Saturday, December 18, 2010SUSPENSION LETTER WRITTEN
Friday, December 17, 2010ASSIGNED TO EXAMINER
Sunday, September 12, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, September 11, 2010NEW APPLICATION ENTERED

Related Keywords

syndax treatment cancer research field information providing pharmaceuticals development services scientific